c-Myc tag Peptide: Precision Tool for Immunoassays and Transcription Factor Research

Executive Summary: The c-Myc tag Peptide (SKU A6003, APExBIO) is a synthetic peptide matching residues 410–419 of human c-Myc, enabling specific displacement of c-Myc-tagged fusion proteins in immunoassays (APExBIO product page). It serves as a robust competitive inhibitor for anti-c-Myc antibody binding, enhancing assay specificity and reproducibility (c-myc-peptide.com). The c-Myc protein is a proto-oncogenic transcription factor regulating cell proliferation, apoptosis, and differentiation (Wu et al., 2021). The peptide is highly soluble in DMSO (≥60.17 mg/mL) and water with sonication (≥15.7 mg/mL), but insoluble in ethanol. Proper storage at -20°C (desiccated) is essential for maintaining stability; solutions are not recommended for long-term storage.

Biological Rationale

The c-Myc protein is a transcription factor encoded by the MYC proto-oncogene. It regulates critical cellular functions including proliferation, growth, apoptosis, differentiation, and stem cell self-renewal (Wu et al., 2021). c-Myc achieves this by binding E-box DNA sequences and modulating target gene expression. In normal physiology, c-Myc expression is tightly controlled. Dysregulation, gene amplification, or overexpression of c-Myc is frequently observed in diverse cancers, contributing to tumorigenesis and poor prognosis. The use of synthetic c-Myc tag peptides allows researchers to study these regulatory pathways with high specificity. By displacing c-Myc-tagged proteins from anti-c-Myc antibodies in immunoassays, the peptide enables selective analysis of transcription factor dynamics and downstream signaling. This approach is fundamental in dissecting the molecular mechanisms of proto-oncogene function and cancer biology (see detailed mechanism—this article extends those findings to include solubility and workflow benchmarks).

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide (EQKLISEEDL) corresponds to the C-terminal amino acids 410-419 of human c-Myc. In immunoassays, the peptide acts as a competitive inhibitor for anti-c-Myc antibodies. When introduced into an assay containing c-Myc-tagged fusion proteins, the peptide binds to the antibody's recognition site, displacing the fusion protein from the antibody complex. This process enables specific elution of c-Myc-fused proteins and inhibits non-specific antibody interactions (APExBIO product page).

The peptide's high solubility in DMSO (≥60.17 mg/mL) and water with sonication (≥15.7 mg/mL) ensures rapid preparation and integration into diverse assay protocols. Its insolubility in ethanol prevents use in alcohol-based workflows. The peptide structure preserves the key epitope for antibody recognition, ensuring consistent and reproducible antibody displacement (BMS-833923 article—this review clarifies integration with autophagy research not fully covered here).

Evidence & Benchmarks

• c-Myc tag Peptide enables displacement of c-Myc-tagged fusion proteins in immunoassays, validated across multiple cell types (Wu et al., 2021).
• The peptide demonstrates high solubility in DMSO (≥60.17 mg/mL) and in water with ultrasonic treatment (≥15.7 mg/mL), supporting rapid assay setup (APExBIO).
• Specific inhibition of anti-c-Myc antibody binding is confirmed via competition ELISA and immunoprecipitation (c-myc-peptide.com).
• The c-Myc tag Peptide is stable when stored desiccated at -20°C, but diluted solutions should not be stored long-term to prevent degradation (APExBIO).
• c-Myc regulates gene expression for cyclins, ribosomal proteins, and cell cycle control, as demonstrated in cancer cell models (Wu et al., 2021).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is primarily used in immunoassays for the displacement of c-Myc-tagged fusion proteins and for blocking anti-c-Myc antibody binding. It is widely applied in studies of transcription factor regulation, protein-protein interaction mapping, and as a research reagent in cancer biology. Its selectivity and solubility make it compatible with high-throughput and multiplexed assay formats. The peptide is not intended for diagnostic or therapeutic use (APExBIO).

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide does not inhibit endogenous c-Myc protein function or gene expression; it only competes for antibody binding in vitro.
• The peptide cannot be used as a therapeutic agent due to lack of bioactivity in live cells and rapid degradation in biological fluids.
• It is not suitable for protocols requiring ethanol as a solvent, as it is insoluble in ethanol.
• Storing peptide solutions long-term leads to degradation; always prepare fresh aliquots for critical experiments.
• The peptide's competitive displacement is epitope-specific; it will not displace proteins tagged with unrelated epitopes (e.g., FLAG or HA tags).

Workflow Integration & Parameters

Researchers using the c-Myc tag Peptide (A6003) should dissolve the lyophilized peptide in DMSO or water (with sonication) at the recommended concentrations. For immunoprecipitation or ELISA, the peptide is added at a molar excess relative to the tagged protein. Incubation conditions should be optimized for each assay, but typical protocols use 4°C for 1–2 hours. For storage, the lyophilized peptide should remain desiccated at -20°C. Avoid repeated freeze-thaw cycles. Always prepare working solutions fresh and discard unused portions after each experiment. For comprehensive workflow guidance, see this scenario-driven protocol article—the present article updates those recommendations with solubility and epitope specificity data from APExBIO's technical documentation.

Conclusion & Outlook

The c-Myc tag Peptide (A6003, APExBIO) represents a well-validated research reagent for the displacement of c-Myc-tagged proteins and inhibition of anti-c-Myc antibody binding. Its specificity, solubility, and stability parameters support reproducible results in transcription factor and cell proliferation studies. As research into transcriptional regulation and cancer biology advances, the c-Myc tag Peptide will remain a critical tool for mechanistic and translational investigations. Future developments may include derivatives with enhanced stability or multi-epitope compatibility, broadening its utility across experimental paradigms.